|
Daehan New Pharm has officially entered the facial thread lifting market with the launch of ‘TASS-UP,’ a compressed cog thread product designed for facial lifting
2019.03.05
|
|---|
|
Daehan New Pharm launched ‘TASS-UP,’ a compressed cog thread product for the facial thread lifting market. In August 2018, the company signed an exclusive sales agreement with Gishell Group (CEO Kim Jong-woo) for the premium facial thread lift product ‘TESSLIFTSOFT.’ Following this, by releasing TASS-UP, which is the most popularly used compressed cog thread in the market, Daehan New Pharm has further strengthened its position in the facial thread lifting sector.
Facial thread lifting, one of the most popular procedures for maintaining a youthful face, has recently gained popularity over methods like Botox, which have short durations, or fillers that may carry higher risks of side effects.
TESSLIFT, launched last year, is known for its 3D mesh structure that provides natural lifting and volumizing effects, with a longer-lasting impact that has made it especially popular among young women.
However, patients with sagging skin or deep nasolabial folds require stronger lifting effects. Industry experts emphasize that a combination treatment of compressed cog threads like TASS-UP is necessary for such cases.
TASS-UP features thicker cogs than traditional sliced-cut threads, resulting in longer-lasting and more powerful lifting effects, making it suitable for a variety of patients. It is produced using a non-heating process, minimizing degradation of thread components due to heat, which addresses the common problem of thread breakage during long-term storage. Unlike bidirectional cogs, TASS-UP’s three-dimensional cogs are twisted at a consistent angle, enhancing lifting effectiveness.
According to ISAPS (International Society of Aesthetic and Plastic Surgery), Korea’s face lifting market is expected to surge from approximately 10 billion won in 2016 to about 35 billion won by 2020. Thread lifting procedures are favored by clinicians due to their relative ease of performance and low incidence of side effects.
Dr. Choi Ho-seong of Pionacl Clinic stated, “By using the newly released TASS-UP to achieve strong lifting effects and appropriately combining it with the natural, firm, and long-lasting TESSLIFTSOFT, patient satisfaction can be greatly increased.” Dr. Lee Sang-bong of Wonjin Dermatology Clinic noted, “TASS-UP and TESSLIFTSOFT not only produce synergistic effects but also complement the shortcomings of each thread, enhancing both efficacy and cost-effectiveness.”
Daehan New Pharm is strengthening its position as a pharmaceutical bio company specializing in obesity and beauty products. Following a stable launch of facial thread lifting, the company plans to expand its portfolio of facial aesthetic products by introducing various medical devices. |


Home